$MNKD
MANNKIND CORP Stock $mnkd

$mnkd Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000156459023002309 Filed on February 23, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$40.63M	$36.06M	$99.77M
YoY Change	238.78%	188.13%	32.25%
Cost Of Revenue	$5.530M	$16.12M	$16.00M
YoY Change	142.12%	41.02%	-56.7%
Gross Profit	$35.10M	$19.94M	$83.77M
YoY Change	3430.78%	1744.13%	117.66%
Gross Profit Margin	86.39%	55.28%	83.96%
Selling, General & Admin	$23.85M	$22.10M	$91.47M
YoY Change	15.24%	-2.78%	18.16%
% of Gross Profit	67.96%	110.84%	109.2%
Research & Development	$5.605M	$7.156M	$19.72M
YoY Change	58.51%	84.15%	60.18%
% of Gross Profit	15.97%	35.9%	23.54%
Depreciation & Amortization	$1.038M	$1.620M	$3.300M
YoY Change	73.29%	32.79%	65.0%
% of Gross Profit	2.96%	8.13%	3.94%
Operating Expenses	$16.21M	$29.25M	$57.50M
YoY Change	-33.1%	9.91%	-35.92%
Operating Profit	-$5.998M	-$9.316M	-$64.11M
YoY Change	-74.19%	-63.51%	36.34%
Interest Expense	$2.424M	-$8.736M	$9.552M
YoY Change	-187.86%	245.3%	-196.5%
% of Operating Profit
Other Income/Expense, Net	-$3.797M	$105.0K	-$23.29M
YoY Change		10400.0%	9644.77%
Pretax Income	-$9.795M	-$17.95M	-$87.40M
YoY Change	-62.32%	-36.04%	8.0%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$9.795M	-$17.95M	-$87.40M
YoY Change	-62.32%	-36.04%	8.0%
Net Earnings / Revenue	-24.11%	-49.77%	-87.6%
Basic Earnings Per Share	-$0.04		-$0.34
Diluted Earnings Per Share	-$0.04	-$0.07	-$0.34
COMMON SHARES
Basic Shares Outstanding	263.9M	263.2M	257.1M
Diluted Shares Outstanding	264.0M		257.1M

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$166.1M	$170.8M	$170.8M
YoY Change	2.28%	-16.3%	-16.3%
Cash & Equivalents	$85.87M	$69.77M	$69.77M
Short-Term Investments	$80.27M	$101.1M	$101.1M
Other Short-Term Assets	$15.45M	$25.48M	$25.48M
YoY Change	290.81%	631.68%	631.68%
Inventory	$22.00M	$21.77M	$21.77M
Prepaid Expenses
Receivables	$19.71M	$16.80M	$16.80M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$223.3M	$234.9M	$234.9M
YoY Change	21.18%	6.9%	6.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$54.84M	$45.13M	$45.13M
YoY Change	32.29%	23.25%	23.25%
Goodwill	$2.000M	$2.400M
YoY Change
Intangibles	$1.133M	$1.153M
YoY Change
Long-Term Investments	$492.0K	$1.961M	$1.961M
YoY Change	-99.3%	-96.54%	-96.54%
Other Assets	$16.38M	$9.718M	$9.718M
YoY Change	35.83%	18.71%	18.71%
Total Long-Term Assets	$74.84M	$60.39M	$60.39M
YoY Change	-39.67%	-40.46%	-40.46%
TOTAL ASSETS
Total Short-Term Assets	$223.3M	$234.9M	$234.9M
Total Long-Term Assets	$74.84M	$60.39M	$60.39M
Total Assets	$298.1M	$295.3M	$295.3M
YoY Change	-3.3%	-8.06%	-8.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.89M	$11.05M	$11.05M
YoY Change	59.61%	58.88%	58.88%
Accrued Expenses	$33.00M	$35.55M	$18.24M
YoY Change	21.61%	29.67%	-25.08%
Deferred Revenue	$2.316M	$1.733M
YoY Change		109.55%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$21.29M	$9.565M	$9.565M
YoY Change	126.28%	37.09%	37.09%
Total Short-Term Liabilities	$81.85M	$67.30M	$67.30M
YoY Change	53.01%	39.19%	39.19%
LONG-TERM LIABILITIES
Long-Term Debt	$356.7M	$368.0M	$368.0M
YoY Change	-4.9%	-1.79%	-1.79%
Other Long-Term Liabilities	$114.9M	$110.5M	$110.5M
YoY Change	1529.5%	2132.77%	2.87%
Total Long-Term Liabilities	$471.7M	$478.5M	$478.5M
YoY Change	6586.7%	9567.15%	-0.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$81.85M	$67.30M	$67.30M
Total Long-Term Liabilities	$471.7M	$478.5M	$478.5M
Total Liabilities	$553.5M	$545.8M	$545.8M
YoY Change	2.43%	2.89%	2.89%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.227B	-$3.217B
YoY Change	2.26%	3.79%
Common Stock	$2.972B	$2.967B
YoY Change		1.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$255.4M	-$250.5M	-$250.5M
YoY Change
Total Liabilities & Shareholders Equity	$298.1M	$295.3M	$295.3M
YoY Change	-3.3%	-8.06%	-8.06%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$9.795M	-$17.95M	-$87.40M
YoY Change	-62.32%	-36.04%	8.0%
Depreciation, Depletion And Amortization	$1.038M	$1.620M	$3.300M
YoY Change	73.29%	32.79%	65.0%
Cash From Operating Activities	$1.156M	-$2.376M	-$80.68M
YoY Change	-106.33%	-80.76%	30.74%
INVESTING ACTIVITIES
Capital Expenditures	$8.311M	$5.096M	$7.589M
YoY Change	64.38%	-198.19%	-166.19%
Acquisitions			$15.34M
YoY Change
Other Investing Activities	$22.10M	$20.11M	$12.46M
YoY Change	-164.16%	-372.11%	-108.9%
Cash From Investing Activities	$13.79M	$15.01M	$4.874M
YoY Change	-134.91%	-219.33%	-103.22%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.154M	2.825M	21.39M
YoY Change	41.94%	-97.1%	-92.09%
NET CHANGE
Cash From Operating Activities	1.156M	-2.376M	-80.68M
Cash From Investing Activities	13.79M	15.01M	4.874M
Cash From Financing Activities	1.154M	2.825M	21.39M
Net Change In Cash	16.10M	15.46M	-54.42M
YoY Change	-128.28%	-78.66%	-195.43%
FREE CASH FLOW
Cash From Operating Activities	$1.156M	-$2.376M	-$80.68M
Capital Expenditures	$8.311M	$5.096M	$7.589M
Free Cash Flow	-$7.155M	-$7.472M	-$88.27M
YoY Change	-69.3%	4.4%	75.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3607736
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-80926000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16003000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16833000
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	19721000
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6248000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	4811000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	6567000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	163880000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	122464000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	4950000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-61709000
CY2022	mnkd	Discounts And Allowances For Commercial Product Sales Balances From Acquisition DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition	1511000
CY2022	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-932000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17200000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-264000
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0000899460
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P18Y9M18D
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257092000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	249244000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	222585000
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.34
CY2021	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.32
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0263
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.9268
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	mnkd	Longterm Purchase Commitment Renewal Time Period LongtermPurchaseCommitmentRenewalTimePeriod	P2Y
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0311
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.9362
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y5M26D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M6D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y1M24D
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	6977000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	106000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1733000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	827000
CY2022Q4	mnkd	Purchase Obligation Current PurchaseObligationCurrent	9393000
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P19Y9M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-50865
CY2022	dei	Entity Registrant Name EntityRegistrantName	MannKind Corporation
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 Casper Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Danbury
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06810
CY2022	dei	City Area Code CityAreaCode	(818)
CY2022	dei	Local Phone Number LocalPhoneNumber	661-5000
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2022	dei	Trading Symbol TradingSymbol	MNKD
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	910286410
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	263923726
CY2022	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2022	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69767000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	124184000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	101079000
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments	79932000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16801000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4739000
CY2022Q4	us-gaap	Inventory Net InventoryNet	21772000
CY2021Q4	us-gaap	Inventory Net InventoryNet	7152000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25477000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3482000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	234896000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	219489000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45126000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36612000
CY2022Q4	us-gaap	Goodwill Goodwill	2428000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1153000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1961000
CY2021Q4	us-gaap	Long Term Investments LongTermInvestments	56619000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9718000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8441000
CY2022Q4	us-gaap	Assets Assets	295282000
CY2021Q4	us-gaap	Assets Assets	321161000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11052000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6956000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35553000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	27419000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9565000
CY2021	mnkd	Gain Loss On Purchase Commitments GainLossOnPurchaseCommitments	-339000
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	113057000
CY2021Q4	mnkd	Purchase Obligation Current PurchaseObligationCurrent	6170000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	67296000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	48349000
CY2022Q4	mnkd	Promissory Notes Noncurrent PromissoryNotesNoncurrent	8829000
CY2021Q4	mnkd	Promissory Notes Noncurrent PromissoryNotesNoncurrent	18425000
CY2022Q4	mnkd	Accrued Interest Noncurrent AccruedInterestNoncurrent	55000
CY2021Q4	mnkd	Accrued Interest Noncurrent AccruedInterestNoncurrent	404000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-64110000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	94512000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	93525000
CY2022Q4	mnkd	Credit Facility Noncurrent CreditFacilityNoncurrent	39264000
CY2021Q4	mnkd	Credit Facility Noncurrent CreditFacilityNoncurrent	38833000
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	225397000
CY2021Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	223944000
CY2022Q4	mnkd	Purchase Obligation Noncurrent PurchaseObligationNoncurrent	62916000
CY2021Q4	mnkd	Purchase Obligation Noncurrent PurchaseObligationNoncurrent	76659000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5343000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1040000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	37684000
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	19543000
CY2022Q4	mnkd	Milestone Liabilities Noncurrent MilestoneLiabilitiesNoncurrent	4524000
CY2021Q4	mnkd	Milestone Liabilities Noncurrent MilestoneLiabilitiesNoncurrent	4838000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4950000
CY2022Q4	us-gaap	Liabilities Liabilities	545820000
CY2021Q4	us-gaap	Liabilities Liabilities	530510000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	263793305
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	263793305
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	251477562
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	251477562
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2638000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2515000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2964293000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2918205000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3217469000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3130069000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-250538000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-209349000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	295282000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	321161000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	99770000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75442000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65144000
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15084000
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	13233000
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	12312000
CY2022	us-gaap	Selling Expense SellingExpense	53753000
CY2021	us-gaap	Selling Expense SellingExpense	45528000
CY2020	us-gaap	Selling Expense SellingExpense	34365000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	37720000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-47022000
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-47913000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2513000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	112000
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	167000
CY2022	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	9758000
CY2021	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	1373000
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	15011000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31889000
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24675000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	106000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1889000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-8006000
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	15204000
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	9471000
CY2022	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-932000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17200000
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1889000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	4811000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	6567000
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-8006000
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-264000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-102000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-239000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23290000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33904000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9545000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-87400000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80926000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57458000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-218000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-87400000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-80926000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-57240000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	257092000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	249244000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	222585000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-87400000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-80926000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-57240000
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-19000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-87400000
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-57259000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-190526000
CY2020	mnkd	Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures	233000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	519000
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	684000
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	9250000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6511000
CY2020	mnkd	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	11600000
CY2020	mnkd	Stock Issued During Period Value Market Price Stock Purchase Plan StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan	215000
CY2020	mnkd	Adjustments To Additional Paid In Capital Issuance Of Warrants Pursuant To Credit Facility AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility	275000
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-19000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-57240000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-180419000
CY2021	mnkd	Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures	-498000
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1090000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12200000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	38000
CY2021	mnkd	Adjustment To Additional Paid In Capital Premium On Convertible Note AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote	22107000
CY2021	mnkd	Stock Issued During Period Value Market Price Stock Purchase Plan StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan	106000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-80926000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-209349000
CY2022	mnkd	Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures	319000
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2082000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13447000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	19790000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	381000
CY2022	mnkd	Stock Issued During Period Value Market Price Stock Purchase Plan StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan	684000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-87400000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-250538000
CY2022	us-gaap	Profit Loss ProfitLoss	-87400000
CY2021	us-gaap	Profit Loss ProfitLoss	-80926000
CY2020	us-gaap	Profit Loss ProfitLoss	-57240000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	13447000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	12200000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	6511000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	6124000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4215000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2149000
CY2022	us-gaap	Interest Expense InterestExpense	9552000
CY2021	us-gaap	Interest Expense InterestExpense	1372000
CY2021	mnkd	Interest On Milestone Payment InterestOnMilestonePayment	3663000
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	2202000
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	1902000
CY2020	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	496000
CY2022	mnkd	Interest Expense On Promissory Notes InterestExpenseOnPromissoryNotes	325000
CY2021	mnkd	Interest Expense On Promissory Notes InterestExpenseOnPromissoryNotes	1598000
CY2020	mnkd	Interest Expense On Promissory Notes InterestExpenseOnPromissoryNotes	5148000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2987000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1258000
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1177000
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	13233000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-17000
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-19000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11807000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	776000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30222000
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	230000000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7268000
CY2021	mnkd	Proceeds From Sale Leaseback Transaction ProceedsFromSaleLeasebackTransaction	102250000
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3120000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	705000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5670000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4081000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1314000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15552000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	360000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	154000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-523000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	138000
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-227000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4096000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1374000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	793000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-723000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	8814000
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3346000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	19047000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-14567000
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-5910000
CY2022	mnkd	Increase Decrease In Recognized Loss On Purchase Commitments IncreaseDecreaseInRecognizedLossOnPurchaseCommitments	-5709000
CY2021	mnkd	Increase Decrease In Recognized Loss On Purchase Commitments IncreaseDecreaseInRecognizedLossOnPurchaseCommitments	-5892000
CY2020	mnkd	Increase Decrease In Recognized Loss On Purchase Commitments IncreaseDecreaseInRecognizedLossOnPurchaseCommitments	-4751000
CY2022	mnkd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-3309000
CY2021	mnkd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-2135000
CY2020	mnkd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1312000
CY2021	mnkd	Increase Decrease In Accrued Interest On Promissory Notes IncreaseDecreaseInAccruedInterestOnPromissoryNotes	4919000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4950000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-80679000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28128000
CY2022	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	74536000
CY2021	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	196131000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	107340000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	59060000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15341000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7589000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11466000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	801000
CY2022	mnkd	Purchase Of Available For Sale Securities PurchaseOfAvailableForSaleSecurities	5000000
CY2021	mnkd	Purchase Of Available For Sale Securities PurchaseOfAvailableForSaleSecurities	3000000
CY2020	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	20000000
CY2020	us-gaap	Payments To Acquire In Process Research And Development PaymentsToAcquireInProcessResearchAndDevelopment	3983000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4874000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-151537000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	15216000
CY2022	mnkd	Milestone Payments MilestonePayments	1088000
CY2021	mnkd	Milestone Payments MilestonePayments	5000000
CY2022	mnkd	Proceeds From Net Issuance Of Common Stock Associated With Stock Options And Restricted Stock Units ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits	319000
CY2021	mnkd	Proceeds From Net Issuance Of Common Stock Associated With Stock Options And Restricted Stock Units ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits	-498000
CY2020	mnkd	Proceeds From Net Issuance Of Common Stock Associated With Stock Options And Restricted Stock Units ProceedsFromNetIssuanceOfCommonStockAssociatedWithStockOptionsAndRestrictedStockUnits	233000
CY2022	mnkd	Proceeds From Market Price Stock Purchase Plan And From Employee Stock Purchase Plan ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan	2766000
CY2021	mnkd	Proceeds From Market Price Stock Purchase Plan And From Employee Stock Purchase Plan ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan	106000
CY2020	mnkd	Proceeds From Market Price Stock Purchase Plan And From Employee Stock Purchase Plan ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan	215000
CY2022	mnkd	Payment On Financing Liability PaymentOnFinancingLiability	18000
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	11600000
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	10000000
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4873000
CY2021	mnkd	Deposit For Sale Leaseback Transaction DepositForSaleLeasebackTransaction	2000000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	35051000
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10000000
CY2021	mnkd	Payment Of Credit Facility Prepayment Penalty PaymentOfCreditFacilityPrepaymentPenalty	1000000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21388000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	270267000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	49853000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54417000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	57021000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	36941000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	124184000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	67163000
CY2022Q4	mnkd	Discounts And Allowances For Commercial Product Sales DiscountsAndAllowancesForCommercialProductSales	8504000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69767000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	124184000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	67163000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	8852000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	11268000
CY2020	us-gaap	Interest Paid Net InterestPaidNet	3558000
CY2022	mnkd	Reclassification Of Investments From Long Term To Current ReclassificationOfInvestmentsFromLongTermToCurrent	82850000
CY2021	mnkd	Reclassification Of Investments From Long Term To Current ReclassificationOfInvestmentsFromLongTermToCurrent	32654000
CY2022	mnkd	Reclassification Of Convertible Notes And Interest Receivable ReclassificationOfConvertibleNotesAndInterestReceivable	7375000
CY2022	mnkd	Payments On Debt And Interest Through Common Stock Issuance PaymentsOnDebtAndInterestThroughCommonStockIssuance	10270000
CY2021	mnkd	Payments On Debt And Interest Through Common Stock Issuance PaymentsOnDebtAndInterestThroughCommonStockIssuance	15143000
CY2020	mnkd	Payments On Debt And Interest Through Common Stock Issuance PaymentsOnDebtAndInterestThroughCommonStockIssuance	15549000
CY2021	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	4873000
CY2022	mnkd	Addition Of Right Of Use Assets AdditionOfRightOfUseAssets	1812000
CY2021	mnkd	Addition Of Right Of Use Assets AdditionOfRightOfUseAssets	1425000
CY2022	mnkd	Right Of Use Assets Modification RightOfUseAssetsModification	3793000
CY2021	mnkd	Right Of Use Assets Modification RightOfUseAssetsModification	278000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1298000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1264000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	92000
CY2021	mnkd	Common Stock Issuance To Settle Employee Stock Purchase Plan Liability CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability	1090000
CY2020	mnkd	Common Stock Issuance To Settle Employee Stock Purchase Plan Liability CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability	684000
CY2022	mnkd	Contingent Milestone Liability ContingentMilestoneLiability	610000
CY2020	mnkd	Common Stock Issued For Acquisition Of In Process Research And Development CommonStockIssuedForAcquisitionOfInProcessResearchAndDevelopment	9250000
CY2020	mnkd	Issuance Of Warrants Associated With Credit Facility IssuanceOfWarrantsAssociatedWithCreditFacility	275000
CY2020	mnkd	Receivable From Common Stock Offering ReceivableFromCommonStockOffering	226000
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications<span style="font-style:normal;"> — Certain prior year reported amounts have been reclassified to conform with the current year presentation. Changes were made to the consolidated statements of operations to present selling expense as a separate line item and to disclose a single caption for interest expense on all outstanding notes. Changes were made to the consolidated balance sheets to reclassify interest receivable from investments from accounts receivable, net to other assets.</span></p>
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Statement Estimates<span style="font-style:normal;"> — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets.</span></p>
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	99770000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75442000
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	65144000
CY2022	us-gaap	Operating Expenses OperatingExpenses	57497000
CY2021	us-gaap	Operating Expenses OperatingExpenses	38857000
CY2020	us-gaap	Operating Expenses OperatingExpenses	24641000
CY2021Q4	mnkd	Discounts And Allowances For Commercial Product Sales DiscountsAndAllowancesForCommercialProductSales	4227000
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit Risk<span style="font-style:normal;"> — Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market funds and U.S. Treasury securities with original or remaining maturities of 90 days or less at the time of purchase. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.</span>
CY2021	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	100000
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0725
CY2022	mnkd	Number Of Wholesale Distributors NumberOfWholesaleDistributors	3
CY2021	mnkd	Number Of Wholesale Distributors NumberOfWholesaleDistributors	3
CY2022	mnkd	Percentage Of Sales From Major Customers PercentageOfSalesFromMajorCustomers	0.79
CY2021	mnkd	Percentage Of Sales From Major Customers PercentageOfSalesFromMajorCustomers	0.79
CY2022	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	12900000
CY2022	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	300000
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	109933000
CY2021	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	98278000
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-86967000
CY2021	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-80806000
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.34
CY2021	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.32
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	700000
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	500000
CY2022Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0
CY2021Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	152862000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	156976000
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	103733000
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	103669000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	1961000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1948000
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	56619000
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	56433000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	154823000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	158924000
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	160352000
CY2021Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	160102000
CY2022Q4	mnkd	Accrued Interest Receivable AccruedInterestReceivable	600000
CY2022Q4	mnkd	Amount Receivable On Matured Investment AmountReceivableOnMaturedInvestment	5100000
CY2021Q4	mnkd	Accrued Interest Receivable AccruedInterestReceivable	300000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16801000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4739000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2022	mnkd	Percentage Of Revenue From Major Customers Collaborations And Services PercentageOfRevenueFromMajorCustomersCollaborationsAndServices	0.98
CY2022Q4	mnkd	Milestone Rights Liability Current MilestoneRightsLiabilityCurrent	1100000
CY2021Q4	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve	4493000
CY2020Q4	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve	3873000
CY2022	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Provisions PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions	17471000
CY2021	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Provisions PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions	11494000
CY2022	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Deductions PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions	-15320000
CY2021	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Deductions PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions	-10874000
CY2022Q4	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve	6644000
CY2021Q4	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve	4493000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5739000
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	2703000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13815000
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2522000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2218000
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1927000
CY2022Q4	us-gaap	Inventory Net InventoryNet	21772000
CY2021Q4	us-gaap	Inventory Net InventoryNet	7152000
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	2200000
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	1900000
CY2020	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	500000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	143686000
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	134273000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	98560000
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	97661000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45126000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36612000
CY2022	us-gaap	Depreciation Depreciation	3300000
CY2021	us-gaap	Depreciation Depreciation	2000000.0
CY2020	us-gaap	Depreciation Depreciation	1800000
CY2022Q4	us-gaap	Goodwill Goodwill	2400000
CY2022Q4	mnkd	Milestone Rights Liabilities Current And Noncurrent MilestoneRightsLiabilitiesCurrentAndNoncurrent	4800000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	100000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	100000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	100000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	100000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	100000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	700000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14906000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14022000
CY2022Q4	mnkd	Customer Discounts And Allowances CustomerDiscountsAndAllowances	8504000
CY2021Q4	mnkd	Customer Discounts And Allowances CustomerDiscountsAndAllowances	4227000
CY2022Q4	mnkd	Returns Reserve For Acquired Product ReturnsReserveForAcquiredProduct	1013000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1136000
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	895000
CY2022Q4	us-gaap	Direct Financing Lease Deferred Selling Profit DirectFinancingLeaseDeferredSellingProfit	1304000
CY2021Q4	us-gaap	Direct Financing Lease Deferred Selling Profit DirectFinancingLeaseDeferredSellingProfit	1380000
CY2022Q4	mnkd	Current Portion Of Milestone Right Liability CurrentPortionOfMilestoneRightLiability	924000
CY2021Q4	mnkd	Current Portion Of Milestone Right Liability CurrentPortionOfMilestoneRightLiability	1088000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2201000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2166000
CY2021Q4	mnkd	Retail Inventory Purchase RetailInventoryPurchase	875000
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	846000
CY2021Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	786000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4719000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1980000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35553000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	27419000
CY2021Q4	mnkd	Discounts And Allowances For Commercial Product Sales DiscountsAndAllowancesForCommercialProductSales	4227000
CY2020Q4	mnkd	Discounts And Allowances For Commercial Product Sales DiscountsAndAllowancesForCommercialProductSales	3688000
CY2022	mnkd	Discounts And Allowances For Commercial Product Sales Provisions DiscountsAndAllowancesForCommercialProductSalesProvisions	23369000
CY2021	mnkd	Discounts And Allowances For Commercial Product Sales Provisions DiscountsAndAllowancesForCommercialProductSalesProvisions	13057000
CY2022	mnkd	Discounts And Allowances For Commercial Product Sales Deductions DiscountsAndAllowancesForCommercialProductSalesDeductions	20603000
CY2021	mnkd	Discounts And Allowances For Commercial Product Sales Deductions DiscountsAndAllowancesForCommercialProductSalesDeductions	12518000
CY2022Q4	us-gaap	Senior Notes SeniorNotes	225397000
CY2021Q4	us-gaap	Senior Notes SeniorNotes	223944000
CY2022Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	8829000
CY2021Q4	us-gaap	Notes Payable Related Parties Noncurrent NotesPayableRelatedPartiesNoncurrent	18425000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	273490000
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	281202000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6667000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	20000000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	22163000
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	230000000
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	278830000
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	235000
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5105000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	273490000
CY2022	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	Principal on each term loan advance under Tranche 1 and Tranche 2 are payable in 24 equal monthly installments beginning September 1, 2023, until paid in full on August 1, 2025.
CY2019Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-11-03
CY2021Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-12-31
CY2022	mnkd	Amortization Of Debt Discount AmortizationOfDebtDiscount	431000
CY2021	mnkd	Amortization Of Debt Discount AmortizationOfDebtDiscount	377000
CY2020	mnkd	Amortization Of Debt Discount AmortizationOfDebtDiscount	268000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1453000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1215000
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	101000
CY2022Q4	mnkd	Milestone Rights Liabilities Current And Noncurrent MilestoneRightsLiabilitiesCurrentAndNoncurrent	4800000
CY2021Q4	mnkd	Milestone Rights Liabilities Current And Noncurrent MilestoneRightsLiabilitiesCurrentAndNoncurrent	5900000
CY2022	mnkd	Payment For Milestone Rights Liabilities PaymentForMilestoneRightsLiabilities	5000000.0
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	900000
CY2021	mnkd	Payment For Milestone Rights Liabilities PaymentForMilestoneRightsLiabilities	5000000.0
CY2021Q4	mnkd	Milestone Rights Liability Current MilestoneRightsLiabilityCurrent	1300000
CY2021Q4	mnkd	Milestone Rights Liabilities Current And Noncurrent MilestoneRightsLiabilitiesCurrentAndNoncurrent	5900000
CY2021Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1100000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20370000
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	34937000
CY2022	mnkd	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	46971000
CY2021	mnkd	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	21707000
CY2022	mnkd	Contract With Customer Liability Collaborations And Services Revenue ContractWithCustomerLiabilityCollaborationsAndServicesRevenue	-27924000
CY2021	mnkd	Contract With Customer Liability Collaborations And Services Revenue ContractWithCustomerLiabilityCollaborationsAndServicesRevenue	-36274000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	39417000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20370000
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	50900000
CY2021Q4	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	5000000.0
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9600000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	94500000
CY2022Q4	mnkd	Debt Instrument Measurement Input After Change DebtInstrumentMeasurementInputAfterChange	0.10
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	263793305
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	263793305
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	251477562
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	251477562
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	100000
CY2021	mnkd	Market Price Stock Purchase Plan MarketPriceStockPurchasePlan	25000
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	700000
CY2022	mnkd	Market Price Stock Purchase Plan MarketPriceStockPurchasePlan	252176
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10732513
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.01
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	34543000
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1196391
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-87400000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-80926000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-57240000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257092000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	249244000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	222585000
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	75451760
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	69998009
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	32745273
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9074587
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	11838329
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2802796
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13447000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12200000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6511000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.79
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	116767
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.82
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	344768
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	6.31
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9074587
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.06
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	29512000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7776518
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.23
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25315000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	970000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	3200000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2300000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4500000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2400000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1700000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	500000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000000.0
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000.0
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	9538032
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.40
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	5120682
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.95
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1551088
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	2.82
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	1269297
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	3.97
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	11838329
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.65
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	4400000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	6700000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2500000
CY2022Q4	mnkd	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding	43200000
CY2021Q4	mnkd	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding	19300000
CY2020Q4	mnkd	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding	13300000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	104100000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	94500000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9600000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	100500000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	93500000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	7000000.0
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1380000
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.090
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.090
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5343000
CY2022	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	9758000
CY2021	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	1373000
CY2022Q4	mnkd	Finance Lease Liability Discounted Payments Due Next Twelve Months FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths	9774000
CY2022Q4	mnkd	Finance Lease Liability Discounted Payments Due Year Two FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo	10018000
CY2022Q4	mnkd	Finance Lease Liability Discounted Payments Due Year Three FinanceLeaseLiabilityDiscountedPaymentsDueYearThree	10269000
CY2022Q4	mnkd	Finance Lease Liability Discounted Payments Due Year Four FinanceLeaseLiabilityDiscountedPaymentsDueYearFour	10533000
CY2022Q4	mnkd	Finance Lease Liability Discounted Payments Due Year Five FinanceLeaseLiabilityDiscountedPaymentsDueYearFive	10849000
CY2022Q4	mnkd	Finance Lease Liability Discounted Payments Due After Year Five FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive	188453000
CY2022Q4	mnkd	Finance Lease Liability Discounted Payments Due FinanceLeaseLiabilityDiscountedPaymentsDue	239896000
CY2022Q4	mnkd	Finance Lease Liability Discounted Excess Amount FinanceLeaseLiabilityDiscountedExcessAmount	132936000
CY2022Q4	mnkd	Finance Lease Liability Discounted Debt Issuance Costs FinanceLeaseLiabilityDiscountedDebtIssuanceCosts	2883000
CY2022Q4	mnkd	Finance Lease Liability Discounted FinanceLeaseLiabilityDiscounted	104077000
CY2021	mnkd	Payment Of Long Term Purchase Commitment Amendment Fee PaymentOfLongTermPurchaseCommitmentAmendmentFee	2000000.0
CY2022Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	8800000
CY2022Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	14600000
CY2022Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	15500000
CY2022Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	19400000
CY2022Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	9200000
CY2022	mnkd	Long Term Purchase Commitment Expiration Date LongTermPurchaseCommitmentExpirationDate	2027-12-31
CY2022	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	The Company will receive a six-month concession at the start of the lease extension period on July 31, 2023. The Company has no further right to extend the lease term beyond the extension period.
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6714000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2284000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1304000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1040000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6647000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	2420000
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1525000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	863000
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	1403000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	274000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	515000
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	394000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1823000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1867000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1797000
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2020	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1800000
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1500000
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	900000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-87400000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-80926000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-57458000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-87400000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80926000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-57458000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-218000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-218000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5606000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5170000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-4377000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4334000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-14461000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-469000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9940000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-19631000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4846000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-218000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-9940000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-19631000
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-4846000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	542537000
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	542800000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	78804000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	78804000
CY2022Q4	mnkd	Deferred Tax Assets Capitalized Research Expenses DeferredTaxAssetsCapitalizedResearchExpenses	4369000
CY2022Q4	mnkd	Deferred Tax Assets Milestone Rights DeferredTaxAssetsMilestoneRights	1331000
CY2021Q4	mnkd	Deferred Tax Assets Milestone Rights DeferredTaxAssetsMilestoneRights	1440000
CY2022Q4	mnkd	Deferred Tax Assets Tax Deferred Expense Accrual Adjustment DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment	2675000
CY2021Q4	mnkd	Deferred Tax Assets Tax Deferred Expense Accrual Adjustment DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment	2591000
CY2022Q4	mnkd	Deferred Tax Assets Loss On Purchase Commitment DeferredTaxAssetsLossOnPurchaseCommitment	23117000
CY2021Q4	mnkd	Deferred Tax Assets Loss On Purchase Commitment DeferredTaxAssetsLossOnPurchaseCommitment	24845000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7686000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5684000
CY2022Q4	mnkd	Deferred Tax Assets Capitalized Costs DeferredTaxAssetsCapitalizedCosts	8058000
CY2021Q4	mnkd	Deferred Tax Assets Capitalized Costs DeferredTaxAssetsCapitalizedCosts	7518000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	3204000
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	2568000
CY2022Q4	mnkd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1624000
CY2021Q4	mnkd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	588000
CY2022Q4	mnkd	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	10991000
CY2021Q4	mnkd	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	5696000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	22157000
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	22983000
CY2022Q4	mnkd	Deferred Tax Assets Product Revenue And Costs DeferredTaxAssetsProductRevenueAndCosts	370000
CY2021Q4	mnkd	Deferred Tax Assets Product Revenue And Costs DeferredTaxAssetsProductRevenueAndCosts	404000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	706923000
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	695921000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	705034000
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	695094000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1889000
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	827000
CY2022Q4	mnkd	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1640000
CY2021Q4	mnkd	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	555000
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	249000
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	272000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1889000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	827000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.012
CY2021	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.044
CY2020	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.061
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.004
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.005
CY2022	mnkd	Effective Income Tax Rate Reconciliation Expirations Of Attribute EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute	-0.132
CY2021	mnkd	Effective Income Tax Rate Reconciliation Expirations Of Attribute EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute	-0.059
CY2020	mnkd	Effective Income Tax Rate Reconciliation Expirations Of Attribute EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute	-0.066
CY2022	mnkd	Effective Income Tax Rate Reconciliation Foreign Withholding Tax EffectiveIncomeTaxRateReconciliationForeignWithholdingTax	0.000
CY2021	mnkd	Effective Income Tax Rate Reconciliation Foreign Withholding Tax EffectiveIncomeTaxRateReconciliationForeignWithholdingTax	0.000
CY2020	mnkd	Effective Income Tax Rate Reconciliation Foreign Withholding Tax EffectiveIncomeTaxRateReconciliationForeignWithholdingTax	0.004
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.072
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.112
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.078
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.004
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	705000000.0
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-9900000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-19600000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	2200000000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	1700000000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	499600000
CY2022	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	Pursuant to IRC Sections 382 and 383, annual use of the Company’s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.
CY2004Q3	mnkd	Operating Loss Carryforwards Subject To Limitation OperatingLossCarryforwardsSubjectToLimitation	105800000
CY2004Q3	mnkd	Net Operating Loss Carryforward Annual Limitation NetOperatingLossCarryforwardAnnualLimitation	13000000.0
CY2022Q4	mnkd	Deferred Tax Assets Tax Credit Carryforwards Research Expire DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire	1100000
CY2022	mnkd	Research And Development Credits Begin To Expire ResearchAndDevelopmentCreditsBeginToExpire	2023
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	268902000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0

Files In Submission

Name	View Source	Status
mnkd-20221231_cal.xml	Edgar Link	unprocessable
mnkd-20221231_lab.xml	Edgar Link	unprocessable
mnkd-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mnkd-20221231_pre.xml	Edgar Link	unprocessable
0001564590-23-002309-index-headers.html	Edgar Link	pending
0001564590-23-002309-index.html	Edgar Link	pending
0001564590-23-002309.txt	Edgar Link	pending
0001564590-23-002309-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g1ow311dygir000001.jpg	Edgar Link	pending
g3puwq45lgum000001.jpg	Edgar Link	pending
g3puwq45lgum000002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mnkd-10k_20221231.htm	Edgar Link	pending
mnkd-20221231.xsd	Edgar Link	pending
mnkd-ex1042_615.htm	Edgar Link	pending
mnkd-ex1043_616.htm	Edgar Link	pending
mnkd-ex1049_458.htm	Edgar Link	pending
mnkd-ex1050_456.htm	Edgar Link	pending
mnkd-ex1051_457.htm	Edgar Link	pending
mnkd-ex1052_455.htm	Edgar Link	pending
mnkd-ex1053_454.htm	Edgar Link	pending
mnkd-ex231_9.htm	Edgar Link	pending
mnkd-ex311_7.htm	Edgar Link	pending
mnkd-ex312_8.htm	Edgar Link	pending
mnkd-ex321_10.htm	Edgar Link	pending
mnkd-ex322_6.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
mnkd-10k_20221231_htm.xml	Edgar Link	completed
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNKD
MANNKIND CORP Stock $mnkd

2023 Q1 Form 10-K Financial Statement

#000156459023002309 Filed on February 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNKD MANNKIND CORP Stock $mnkd

2023 Q1 Form 10-K Financial Statement

#000156459023002309 Filed on February 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNKD
MANNKIND CORP Stock $mnkd